SCHEMBL2958029

SCHEMBL2958029

CCOP(=O)(OCC)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.40
LMNA P02545 2/20 0.40
GAA P10253 2/20 0.40
HDAC1 Q13547 1/20 0.40
CYP1A1 P04798 1/20 0.38
CYP1B1 Q16678 1/20 0.38
MAOB P27338 1/20 0.38
NPSR1 Q6W5P4 2/20 0.38
UTRN P46939 1/20 0.38
FPR2 P25090 2/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA5A P35218 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA5B Q9Y2D0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6829825 0.84 TDP1 (0.49) TDP1NPSR1MEN1KMT2ACA12
SCHEMBL14130804 0.83 HMGCR (0.41) TDP1LMNAHDAC1MEN1KMT2A
SCHEMBL14255603 0.83 NR1H2 (0.49) LMNA
SCHEMBL2957755 0.82 TP53 (0.38) TDP1LMNAGAACYP1A1CYP1B1
SCHEMBL12229711 0.81 LMNA (0.43) LMNAGAANPSR1MEN1KMT2A
SCHEMBL12229689 0.80 NPSR1 (0.47) LMNAGAAHDAC1NPSR1MEN1
SCHEMBL895236 0.79 ALDH1A1 (0.47) TDP1LMNAGAANPSR1UTRN
SCHEMBL25341898 0.78 PTPN1 (0.37) LMNAHDAC1CYP1A1CYP1B1MAOB
SCHEMBL30519414 0.78 PTPN1 (0.37) LMNAHDAC1CYP1A1CYP1B1MAOB
SCHEMBL2958530 0.78 FPR2 (0.39) LMNAGAACYP1A1CYP1B1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7754200-B2 Phosphate transport inhibitors GENZYME CORPORATION (US) 2010-07-13 US disclosed
US-20060280719-A1 Phosphate transport inhibitors JOZEFIAK THOMAS H 2006-12-14 US disclosed
US-7109184-B2 Phosphate transport inhibitors GENZYME CORPORATION (US) 2006-09-19 US disclosed
EP-1485391-B1 PHOSPHATE TRANSPORT INHIBITORS GENZYME CORP (US) 2006-08-23 EP disclosed
EP-1485391-A2 PHOSPHATE TRANSPORT INHIBITORS GENZYME CORPORATION (US) 2004-12-15 EP disclosed
US-20040019020-A1 Phosphate transport inhibitors GELTEX PHARMACEUTICALS, INC. 2004-01-29 US disclosed
WO-2003080630-A2 PHOSPHATE TRANSPORT INHIBITORS GENZYME CORPORATION (US) 2003-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060280719-A1 Phosphate transport inhibitors SLC34A2, SLC34A1, SLC43A1 TDP1 2803/4885LMNA 4632/4885GAA 3722/4885
US-20040019020-A1 Phosphate transport inhibitors SLC34A2, SLC43A1, SLC34A1 TDP1 3488/4885LMNA 4426/4885GAA 2066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.